Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | ABC transporter, putative | 0.0014 | 0.2064 | 0.2064 |
Schistosoma mansoni | multidrug resistance protein | 0.0018 | 0.3253 | 0.1497 |
Trypanosoma cruzi | trans-sialidase, putative | 0.003 | 0.6973 | 0.6593 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.003 | 0.6974 | 0.6595 |
Echinococcus granulosus | multidrug resistance associated protein 4 | 0.0011 | 0.1114 | 0.1114 |
Giardia lamblia | MRP-like ABC transporter | 0.0018 | 0.3253 | 1 |
Toxoplasma gondii | ubiquitin-conjugating enzyme subfamily protein | 0.0039 | 1 | 1 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0014 | 0.2064 | 0.2064 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0014 | 0.2064 | 0.2064 |
Loa Loa (eye worm) | hypothetical protein | 0.0014 | 0.2064 | 0.0994 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0014 | 0.2064 | 0.2064 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0014 | 0.2064 | 0.2064 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0014 | 0.2064 | 0.2064 |
Schistosoma mansoni | multidrug resistance protein | 0.0018 | 0.3253 | 0.1497 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0014 | 0.2064 | 0.2064 |
Echinococcus granulosus | multidrug resistance associated protein 7 | 0.0018 | 0.3253 | 0.3253 |
Trypanosoma cruzi | multidrug resistance protein E, putative | 0.0018 | 0.3253 | 0.2407 |
Entamoeba histolytica | ABC transporter, putative | 0.0018 | 0.3253 | 0.1497 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0014 | 0.2064 | 0.2064 |
Entamoeba histolytica | ubiquitin-conjugating enzyme family protein | 0.0039 | 1 | 1 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0014 | 0.2064 | 0.2064 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.003 | 0.6974 | 0.6595 |
Brugia malayi | ubiquitin conjugating enzyme protein 13 | 0.0039 | 1 | 1 |
Echinococcus multilocularis | ATP binding cassette sub family B | 0.0014 | 0.199 | 0.199 |
Brugia malayi | ABC transporter transmembrane region family protein | 0.0018 | 0.3253 | 0.1497 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.003 | 0.6974 | 0.6595 |
Echinococcus granulosus | 5'partial|ATP binding cassette sub family B | 0.0014 | 0.199 | 0.199 |
Echinococcus granulosus | ubiquitin conjugating enzyme E2 N | 0.0039 | 1 | 1 |
Trichomonas vaginalis | ABC transporter, putative | 0.0014 | 0.2064 | 0.2064 |
Giardia lamblia | Multidrug resistance-associated protein 1 | 0.0018 | 0.3253 | 1 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0014 | 0.2064 | 0.2064 |
Echinococcus multilocularis | multidrug resistance associated protein 1 | 0.0018 | 0.3253 | 0.3253 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0014 | 0.2064 | 0.2064 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0014 | 0.2064 | 0.2064 |
Giardia lamblia | Multidrug resistance-associated protein 1 | 0.0018 | 0.3253 | 1 |
Trypanosoma brucei | trans-sialidase, putative | 0.003 | 0.6974 | 0.5515 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.003 | 0.6974 | 0.6595 |
Chlamydia trachomatis | ABC transporter ATP binding protein/permease | 0.0014 | 0.2064 | 0.5 |
Plasmodium vivax | ubiquitin-conjugating enzyme E2 N, putative | 0.0039 | 1 | 1 |
Mycobacterium tuberculosis | Probable transmembrane multidrug efflux pump | 0.0014 | 0.2064 | 0.5 |
Entamoeba histolytica | multidrug resistance protein, putative | 0.0018 | 0.3253 | 0.1497 |
Echinococcus multilocularis | multidrug resistance protein 1 | 0.0014 | 0.2064 | 0.2064 |
Trichomonas vaginalis | taga, putative | 0.0014 | 0.2064 | 0.2064 |
Trypanosoma cruzi | trans-sialidase, putative | 0.003 | 0.6973 | 0.6593 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.003 | 0.6974 | 0.6595 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0014 | 0.2064 | 0.2064 |
Entamoeba histolytica | hypothetical protein | 0.0018 | 0.3253 | 0.1497 |
Onchocerca volvulus | 0.0014 | 0.2064 | 0.5 | |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.003 | 0.6974 | 0.6595 |
Entamoeba histolytica | ATP-binding cassette protein, putative | 0.0018 | 0.3253 | 0.1497 |
Plasmodium falciparum | ubiquitin-conjugating enzyme E2 N, putative | 0.0039 | 1 | 1 |
Entamoeba histolytica | ATP-binding cassette protein, putative | 0.0018 | 0.3253 | 0.1497 |
Trichomonas vaginalis | ubiquitin-conjugating enzyme E2, putative | 0.0039 | 1 | 1 |
Loa Loa (eye worm) | ATP-binding cassette sub-family B member 2 | 0.0014 | 0.2064 | 0.0994 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.3178 | 0.2258 |
Trichomonas vaginalis | ubiquitin-conjugating enzyme E2, putative | 0.0039 | 1 | 1 |
Trichomonas vaginalis | ABC transporter, putative | 0.0014 | 0.2064 | 0.2064 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0014 | 0.2064 | 0.2064 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0014 | 0.2064 | 0.2064 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0014 | 0.2064 | 0.2064 |
Trypanosoma cruzi | multidrug resistance-associated protein, putative | 0.0018 | 0.3253 | 0.2407 |
Echinococcus multilocularis | multidrug resistance associated protein 4 | 0.0011 | 0.1114 | 0.1114 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0014 | 0.2064 | 0.2064 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0014 | 0.2064 | 0.2064 |
Trichomonas vaginalis | ABC transporter, putative | 0.0014 | 0.2064 | 0.2064 |
Leishmania major | ATP-binding cassette protein subfamily C, member 6, putative | 0.0018 | 0.3253 | 0.1497 |
Trypanosoma cruzi | trans-sialidase, putative | 0.003 | 0.6973 | 0.6593 |
Trypanosoma cruzi | trans-sialidase, putative | 0.003 | 0.6974 | 0.6595 |
Toxoplasma gondii | ABC transporter transmembrane region domain-containing protein | 0.0018 | 0.3253 | 0.1497 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0014 | 0.2064 | 0.2064 |
Leishmania major | ATP-binding cassette protein subfamily C, member 5, putative | 0.0018 | 0.3253 | 0.1497 |
Trichomonas vaginalis | ABC transporter, half transporter, putative | 0.0014 | 0.2064 | 0.2064 |
Trichomonas vaginalis | abcb9, putative | 0.0014 | 0.2064 | 0.2064 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0014 | 0.2064 | 0.2064 |
Trypanosoma brucei | trans-sialidase, putative | 0.003 | 0.6974 | 0.5515 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.003 | 0.6974 | 0.6595 |
Leishmania major | ubiquitin-conjugating enzyme e2, putative | 0.0039 | 1 | 1 |
Loa Loa (eye worm) | ubiquitin conjugating enzyme protein 13 | 0.0039 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.3253 | 0.2343 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0014 | 0.2064 | 0.2064 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.003 | 0.6974 | 0.6595 |
Loa Loa (eye worm) | hypothetical protein | 0.0014 | 0.2064 | 0.0994 |
Trichomonas vaginalis | abcb9, putative | 0.0014 | 0.2064 | 0.2064 |
Giardia lamblia | ABC transporter, putative | 0.0018 | 0.3253 | 1 |
Trypanosoma cruzi | trans-sialidase, putative | 0.003 | 0.6974 | 0.6595 |
Trypanosoma cruzi | ubiquitin-conjugating enzyme E2, putative | 0.0039 | 1 | 1 |
Trypanosoma brucei | trans-sialidase, putative | 0.003 | 0.6974 | 0.5515 |
Trypanosoma brucei | trans-sialidase | 0.003 | 0.6974 | 0.5515 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0014 | 0.2064 | 0.2064 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.0014 | 0.2064 | 0.2064 |
Trypanosoma cruzi | trans-sialidase, putative | 0.003 | 0.6974 | 0.6595 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0014 | 0.2064 | 0.2064 |
Leishmania major | ATP-binding cassette protein subfamily C, member 2, putative | 0.0018 | 0.3253 | 0.1497 |
Schistosoma mansoni | multidrug resistance protein | 0.0018 | 0.3253 | 0.1497 |
Brugia malayi | multidrug resistance related protein 1 | 0.0018 | 0.3253 | 0.1497 |
Leishmania major | ABC-thiol transporter | 0.0018 | 0.3253 | 0.1497 |
Loa Loa (eye worm) | hypothetical protein | 0.0014 | 0.199 | 0.091 |
Trypanosoma brucei | ubiquitin-protein ligase, putative | 0.0039 | 1 | 1 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0014 | 0.2064 | 0.2064 |
Leishmania major | ATP-binding cassette protein subfamily C, member 1, putative | 0.0018 | 0.3253 | 0.1497 |
Trypanosoma brucei | trans-sialidase, putative | 0.003 | 0.6974 | 0.5515 |
Trichomonas vaginalis | ABC transporter, half transporter, putative | 0.0014 | 0.2064 | 0.2064 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0014 | 0.2064 | 0.2064 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0014 | 0.2064 | 0.2064 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.3253 | 0.2343 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.003 | 0.6974 | 0.6595 |
Trypanosoma cruzi | trans-sialidase, putative | 0.003 | 0.6973 | 0.6593 |
Loa Loa (eye worm) | multidrug resistance protein 3 | 0.0014 | 0.2064 | 0.0994 |
Entamoeba histolytica | ATP-binding cassette protein, putative | 0.0018 | 0.3253 | 0.1497 |
Echinococcus multilocularis | ubiquitin conjugating enzyme E2 N | 0.0039 | 1 | 1 |
Leishmania major | p-glycoprotein e | 0.0018 | 0.3253 | 0.1497 |
Trypanosoma cruzi | ubiquitin-conjugating enzyme E2, putative | 0.0039 | 1 | 1 |
Trichomonas vaginalis | abcb9, putative | 0.0014 | 0.2064 | 0.2064 |
Leishmania major | pentamidine resistance protein 1 | 0.0018 | 0.3253 | 0.1497 |
Loa Loa (eye worm) | ubiquitin conjugating enzyme protein 13 | 0.0039 | 1 | 1 |
Echinococcus multilocularis | multidrug resistance associated protein 7 | 0.0018 | 0.3253 | 0.3253 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.003 | 0.6974 | 0.6595 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.0014 | 0.2064 | 0.2064 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.0014 | 0.2064 | 0.2064 |
Echinococcus granulosus | multidrug resistance associated protein 1 | 0.0018 | 0.3253 | 0.3253 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.0014 | 0.2064 | 0.2064 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0014 | 0.2064 | 0.2064 |
Trypanosoma brucei | trans-sialidase, putative | 0.003 | 0.6974 | 0.5515 |
Schistosoma mansoni | multidrug resistance protein | 0.0018 | 0.3253 | 0.1497 |
Trypanosoma cruzi | trans-sialidase, Group I, putative | 0.003 | 0.6974 | 0.6595 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.0014 | 0.2064 | 0.2064 |
Echinococcus multilocularis | multidrug resistance protein 1 | 0.0014 | 0.2064 | 0.2064 |
Trypanosoma cruzi | multidrug resistance-associated protein, putative | 0.0018 | 0.3253 | 0.2407 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.0014 | 0.2064 | 0.2064 |
Entamoeba histolytica | ATP-binding cassette protein, putative | 0.0018 | 0.3253 | 0.1497 |
Loa Loa (eye worm) | ABC transporter transmembrane region family protein | 0.0018 | 0.3253 | 0.2343 |
Schistosoma mansoni | ubiquitin conjugating enzyme 13 | 0.0039 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MIC (functional) | > 64 ug ml-1 | Antibacterial activity against Escherichia coli ATCC 25922 assessed as growth inhibition after 16 to 18 hr NCCLS agar dilution method | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.